Safety Study Of Cetuximab Plus Dasatinib (BMS-354825) in Treating Advanced Solid Malignancies

Clinical trial NCT00388427 · COMPLETED

Trial details

NCT number: NCT00388427
Sponsor: University of Pittsburgh
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Malignant Solid Tumour

Start date: 2007-06-01
Primary completion: 2009-07-01
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.